BioLine Rx Ltd (BLRX)
0.615
-0.03
(-4.64%)
USD |
NASDAQ |
May 15, 16:00
0.615
0.00 (0.00%)
After-Hours: 16:10
BioLine Rx Price to Book Value: 3.718 for May 15, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 14, 2024 | 3.899 |
| May 13, 2024 | 3.760 |
| May 10, 2024 | 3.942 |
| May 09, 2024 | 4.142 |
| May 08, 2024 | 3.989 |
| May 07, 2024 | 4.127 |
| May 06, 2024 | 4.342 |
| May 03, 2024 | 4.111 |
| May 02, 2024 | 3.991 |
| May 01, 2024 | 4.063 |
| April 30, 2024 | 4.047 |
| April 29, 2024 | 3.869 |
| April 26, 2024 | 3.697 |
| April 25, 2024 | 3.478 |
| April 24, 2024 | 3.706 |
| April 23, 2024 | 3.850 |
| April 22, 2024 | 4.093 |
| April 19, 2024 | 3.969 |
| April 18, 2024 | 3.870 |
| April 17, 2024 | 3.757 |
| April 16, 2024 | 3.866 |
| April 15, 2024 | 3.870 |
| April 12, 2024 | 4.333 |
| April 11, 2024 | 4.232 |
| April 10, 2024 | 4.448 |
| Date | Value |
|---|---|
| April 09, 2024 | 4.277 |
| April 08, 2024 | 4.604 |
| April 05, 2024 | 4.902 |
| April 04, 2024 | 4.978 |
| April 03, 2024 | 5.006 |
| April 02, 2024 | 5.014 |
| April 01, 2024 | 5.200 |
| March 28, 2024 | 6.136 |
| March 27, 2024 | 6.081 |
| March 26, 2024 | 5.643 |
| March 25, 2024 | 7.122 |
| March 22, 2024 | 7.56 |
| March 21, 2024 | 6.574 |
| March 20, 2024 | 6.519 |
| March 19, 2024 | 6.464 |
| March 18, 2024 | 6.300 |
| March 15, 2024 | 6.30 |
| March 14, 2024 | 6.464 |
| March 13, 2024 | 6.410 |
| March 12, 2024 | 6.30 |
| March 11, 2024 | 6.245 |
| March 08, 2024 | 6.464 |
| March 07, 2024 | 6.774 |
| March 06, 2024 | 6.957 |
| March 05, 2024 | 7.286 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3946
Minimum
Mar 18 2020
10.23
Maximum
Nov 16 2023
2.349
Average
1.352
Median
Aug 11 2020
Price to Book Value Benchmarks
| Compugen Ltd | 3.011 |
| Pluri Inc | -- |
| XTL Biopharmaceuticals Ltd | 6.725 |
| Can Fite Biofarma Ltd | 1.647 |
| BiomX Inc | 6.363 |
Price to Book Value Related Metrics
| Price | 0.615 |
| Earnings Yield | -146.3% |
| Market Cap | 49.16M |